JP2019529487A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019529487A5 JP2019529487A5 JP2019517027A JP2019517027A JP2019529487A5 JP 2019529487 A5 JP2019529487 A5 JP 2019529487A5 JP 2019517027 A JP2019517027 A JP 2019517027A JP 2019517027 A JP2019517027 A JP 2019517027A JP 2019529487 A5 JP2019529487 A5 JP 2019529487A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound
- cooh
- appearance
- coor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662401762P | 2016-09-29 | 2016-09-29 | |
| US62/401,762 | 2016-09-29 | ||
| PCT/US2017/054053 WO2018064356A1 (en) | 2016-09-29 | 2017-09-28 | Compounds and methods for treating lupus |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019529487A JP2019529487A (ja) | 2019-10-17 |
| JP2019529487A5 true JP2019529487A5 (cg-RX-API-DMAC7.html) | 2020-09-10 |
| JP7086945B2 JP7086945B2 (ja) | 2022-06-20 |
Family
ID=60043386
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019517027A Active JP7086945B2 (ja) | 2016-09-29 | 2017-09-28 | 狼瘡を処置するための化合物および方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11278526B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3518922A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7086945B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102408814B1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3038106A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018064356A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2960051T3 (es) * | 2017-05-22 | 2024-02-29 | Egyt Gyogyszervegyeszeti Gyar | Proceso para la producción de ozanimod |
| AR116479A1 (es) | 2018-09-25 | 2021-05-12 | Quim Sintetica S A | Intermediarios para la síntesis de ozanimod y procedimiento para la preparación del mencionado agonista del receptor de esfingosina-1-fosfato y de dichos intermediarios |
| EP3947363A4 (en) * | 2019-03-29 | 2023-01-04 | Receptos Llc | SPHINGOSINE-1-PHOSPHATE RECEPTOR MODULATORS |
| CN116332794B (zh) * | 2021-12-24 | 2024-10-15 | 上海合全药物研发有限公司 | 一种芳基腈类化合物的制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20080014009A (ko) | 2005-06-08 | 2008-02-13 | 노파르티스 아게 | 폴리시클릭 옥사디아졸 또는 이속사졸, 및 이들의 ｓ１ｐ수용체 리간드로서의 용도 |
| AU2007302262A1 (en) | 2006-09-29 | 2008-04-03 | Novartis Ag | Oxadiazole derivatives with anti-inflammatory and immunosuppressive properties |
| JO2701B1 (en) | 2006-12-21 | 2013-03-03 | جلاكسو جروب ليميتد | Vehicles |
| PT2291080E (pt) | 2008-05-14 | 2015-10-30 | Scripps Research Inst | Novos modelamodeladores dos recetores da esfingosina fosfato |
| CA2780772C (en) * | 2009-11-13 | 2018-01-16 | Receptos, Inc. | Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis |
| US20170165236A1 (en) * | 2013-11-01 | 2017-06-15 | Celgene International Ii Sàrl | Selective sphingosine 1 phosphate receptor modulators and combination therapy therewith |
-
2017
- 2017-09-28 CA CA3038106A patent/CA3038106A1/en active Pending
- 2017-09-28 WO PCT/US2017/054053 patent/WO2018064356A1/en not_active Ceased
- 2017-09-28 US US16/337,292 patent/US11278526B2/en active Active
- 2017-09-28 EP EP17781337.5A patent/EP3518922A1/en active Pending
- 2017-09-28 JP JP2019517027A patent/JP7086945B2/ja active Active
- 2017-09-28 KR KR1020197011411A patent/KR102408814B1/ko active Active